Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vascular Surgery

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    October 2022
  1. RUEL M, Williams A
    A New Effect Modifier of the Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Decision: Physical and Mental Functioning.
    Circulation. 2022;146:1281-1283.
    PubMed    


  2. GOLDMAN S, McCarren M, Sethi GK, Holman W, et al
    Long-Term Mortality Follow-Up of Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Grafting: A Multicenter, Randomized Trial.
    Circulation. 2022;146:1323-1325.
    PubMed    


  3. GAUDINO M, Lytle B
    Right Internal Thoracic Artery for Coronary Bypass Surgery: Did We Get It Wrong?
    Circulation. 2022;146:1266-1267.
    PubMed    


  4. ESCOBAR GA, Oderich GS, Farber MA, de Souza LR, et al
    Results of the North American Complex Abdominal Aortic Debranching (NACAAD) Registry.
    Circulation. 2022;146:1149-1158.
    PubMed     Abstract available


    September 2022
  5. MENTIAS A, Desai MY, Keshvani N, Gillinov AM, et al
    Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States.
    Circulation. 2022 Sep 26:101161CIRCULATIONAHA122059496.
    PubMed     Abstract available


    August 2022
  6. BONACA MP, Morrow DA, Bergmark BA, Berg DD, et al
    Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
    Circulation. 2022 Aug 30:101161CIRCULATIONAHA122059325.
    PubMed     Abstract available


  7. GARGIULO G, Giacoppo D, Jolly SS, Cairns J, et al
    Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061527.
    PubMed     Abstract available


  8. RAO SV, Kirsch B, Bhatt DL, Budaj A, et al
    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
    Circulation. 2022 Aug 27. doi: 10.1161/CIRCULATIONAHA.122.061612.
    PubMed     Abstract available


  9. STABLES RH, Mullen LJ, Elguindy M, Nicholas Z, et al
    Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial.
    Circulation. 2022 Aug 10:101161CIRCULATIONAHA121057793.
    PubMed     Abstract available


    July 2022
  10. KRAWISZ AK, Natesan S, Wadhera RK, Chen S, et al
    Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention.
    Circulation. 2022;146:191-200.
    PubMed     Abstract available


  11. ONO M, Serruys PW, Garg S, Kawashima H, et al
    Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
    Circulation. 2022 Jul 18:101161CIRCULATIONAHA121057021.
    PubMed     Abstract available


  12. HANKEY GJ
    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.
    PubMed    


    June 2022
  13. ABDELHALIM MA, Patel A, Moquet J, Saha P, et al
    Higher Incidence of Chromosomal Aberrations in Operators Performing a Large Volume of Endovascular Procedures.
    Circulation. 2022;145:1808-1810.
    PubMed    


  14. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    PubMed     Abstract available


    May 2022
  15. SHISHEHBOR MH, Zeller T, Werner M, Brodmann M, et al
    Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
    Circulation. 2022;145:1645-1654.
    PubMed     Abstract available


  16. FEARON WF, Zimmermann FM, Ding VY, Zelis JM, et al
    Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Circulation. 2022;145:1655-1662.
    PubMed     Abstract available


    April 2022
  17. PATEL KK
    Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.
    Circulation. 2022;145:1308-1311.
    PubMed    


  18. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed     Abstract available


  19. WHITE HD
    Zooming in on the Enigmas of Type 2 Myocardial Infarction.
    Circulation. 2022;145:1201-1204.
    PubMed    


  20. SEIKE Y, Matsuda H, Shimizu H, Ishimaru S, et al
    Nationwide Analysis of Persistent Type II Endoleak and Late Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in Japan: A Propensity-Matched Analysis.
    Circulation. 2022;145:1056-1066.
    PubMed     Abstract available


    March 2022
  21. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available


  22. MAAMARI DJ, Jaffer FA, Khera AV, Fahed AC, et al
    CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?
    Circulation. 2022;145:721-723.
    PubMed    


    February 2022
  23. DASHWOOD MR, Pinheiro BB, Souza DSR
    Thirty Years of No-Touch Saphenous Vein Harvesting: A Timely Jubilee Gift.
    Circulation. 2022;145:319-320.
    PubMed    


    January 2022
  24. CHEW DS, Cowper PA, Al-Khalidi H, Anstrom KJ, et al
    Cost Effectiveness of Coronary-Artery Bypass Surgery versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
    Circulation. 2022 Jan 19. doi: 10.1161/CIRCULATIONAHA.121.056276.
    PubMed     Abstract available


  25. GRUBB KJ, Kirtane AJ
    The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
    Circulation. 2022;145:155-157.
    PubMed    


    December 2021
  26. LAM CZ, Gulamhusein A, Wald RM
    Liver Cirrhosis and Hepatocellular Carcinoma After the Fontan Operation: Reaching Clarity in the Face of Uncertainty.
    Circulation. 2021;144:1977-1980.
    PubMed    


  27. NII M, Inuzuka R, Inai K, Shimada E, et al
    Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.
    Circulation. 2021;144:2043-2045.
    PubMed    


  28. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
    2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2021 Dec 9:CIR0000000000001039. doi: 10.1161/CIR.0000000000001039.
    PubMed     Abstract available


    October 2021
  29. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available


  30. DAHLE G, Kempfert J
    Fifty Years After the Introduction of Vein Grafts for CABG: New Evidence for a No-Touch Harvesting Approach.
    Circulation. 2021;144:1130-1132.
    PubMed    


  31. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
    The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
    Circulation. 2021;144:1160-1171.
    PubMed     Abstract available


    September 2021
  32. EDGAR L, Akbar N, Braithwaite AT, Krausgruber T, et al
    Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis.
    Circulation. 2021;144:961-982.
    PubMed     Abstract available


  33. TIAN M, Wang X, Sun H, Feng W, et al
    No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.
    Circulation. 2021 Sep 13. doi: 10.1161/CIRCULATIONAHA.121.055525.
    PubMed    


  34. KIM MS, Kim KB
    Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft: Ten-Year Angiographic and Long-Term Clinical Results of the SAVE RITA Trial.
    Circulation. 2021 Sep 8. doi: 10.1161/CIRCULATIONAHA.121.056438.
    PubMed    


    August 2021
  35. XENOGIANNIS I, Zenati M, Bhatt DL, Rao SV, et al
    Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
    Circulation. 2021;144:728-745.
    PubMed     Abstract available


  36. WATERS DD, Stone GW
    Usefulness of Angina to Guide Revascularization Decisions.
    Circulation. 2021;144:524-527.
    PubMed    


    July 2021
  37. MEHTA SR
    Achieving Complete Revascularization for Multivessel Coronary Artery Disease.
    Circulation. 2021;144:110-112.
    PubMed    


    June 2021
  38. DECANO JL, Singh SA, Gasparotto Bueno C, Ho Lee L, et al
    Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARalpha Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.
    Circulation. 2021;143:2454-2470.
    PubMed     Abstract available


    May 2021
  39. TAKAHASHI K, Serruys PW, Gao C, Ono M, et al
    Ten-Year All-Cause Death According to Completeness of Revascularization in Patients with Three-Vessel Disease or Left Main Coronary Artery Disease: Insights from the SYNTAX Extended Survival Study.
    Circulation. 2021 May 20. doi: 10.1161/CIRCULATIONAHA.120.046289.
    PubMed     Abstract available


    April 2021
  40. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
    Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
    PubMed     Abstract available


  41. SHAH R
    Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e807-e808.
    PubMed    


    March 2021
  42. VERRALL CE, Yang JYM, Chen J, Schembri A, et al
    Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults With a Fontan Circulation.
    Circulation. 2021;143:878-891.
    PubMed     Abstract available


    February 2021
  43. ANGIOLILLO DJ, Bhatt DL, Cannon CP, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Circulation. 2021;143:583-596.
    PubMed     Abstract available


    January 2021
  44. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    PubMed     Abstract available


  45. O'FEE K, Panza JA, Brown DL
    Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
    Circulation. 2021;143:205-207.
    PubMed    


    December 2020
  46. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.
    PubMed    


  47. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.
    PubMed    


  48. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.
    PubMed    


  49. IGLESIAS JF, Valgimigli M, Carbone F, Lauriers N, et al
    Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.
    Circulation. 2020;142:2479-2481.
    PubMed    


  50. VLACHOJANNIS GJ, Wilschut JM, Vogel RF, Lemmert ME, et al
    Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
    Circulation. 2020;142:2316-2328.
    PubMed     Abstract available


  51. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    PubMed     Abstract available


  52. CHAITMAN BR, Alexander KP, Cyr DD, Berger JS, et al
    Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.047987.
    PubMed     Abstract available


    November 2020
  53. KIM HS, Kang J, Hwang D, Han JK, et al
    Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
    Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.051700.
    PubMed     Abstract available


  54. ALEXANDER JH, Smith PK
    Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1797-1798.
    PubMed    


    October 2020
  55. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available


  56. FRANCHI F, Rollini F, Been L, Briceno M, et al
    Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
    Circulation. 2020;142:1500-1502.
    PubMed    


  57. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    PubMed     Abstract available


  58. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
    Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
    Circulation. 2020;142:1399-1401.
    PubMed    


  59. LYTLE B, Gaudino M
    Fractional Flow Reserve for Coronary Artery Bypass Surgery.
    Circulation. 2020;142:1315-1316.
    PubMed    


    August 2020
  60. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e76-e77.
    PubMed    


  61. VINCENT F, Van Belle E, Susen S
    Letter by Vincent et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e80-e81.
    PubMed    


  62. O'NEILL WW, Burkhoff D
    Letter by O'Neill and Burkhoff Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e78-e79.
    PubMed    


  63. HELGESTAD OKL, Moller S, Moller JE
    Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e72-e73.
    PubMed    


  64. AMIN AP, Rao SV, Bach RG, Curtis JP, et al
    Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e82-e84.
    PubMed    


  65. CHIEFFO A, Gramegna M, Pappalardo F
    Letter by Chieffo et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e74-e75.
    PubMed    


  66. GARGIULO G, Esposito G, Avvedimento M, Nagler M, et al
    Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:441-454.
    PubMed     Abstract available


  67. KHAN SU, Singh M, Valavoor S, Khan MU, et al
    Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
    Circulation. 2020 Aug 3. doi: 10.1161/CIRCULATIONAHA.120.046308.
    PubMed     Abstract available


    July 2020
  68. FARIDI KF, Tamez H, Strom JB, Song Y, et al
    Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
    Circulation. 2020;142:306-308.
    PubMed    


    June 2020
  69. COLLERAN R, Byrne RA
    Polymer-Free Drug-Eluting Stents: The Importance of the Right Control.
    Circulation. 2020;141:2064-2066.
    PubMed    


  70. O'DONOGHUE ML, Murphy SA, Sabatine MS
    The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Circulation. 2020 Jun 19. doi: 10.1161/CIRCULATIONAHA.120.046251.
    PubMed     Abstract available


  71. CHANDRASHEKHAR Y, Alexander T, Mullasari A, Kumbhani DJ, et al
    Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries.
    Circulation. 2020;141:2004-2025.
    PubMed     Abstract available


  72. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    PubMed     Abstract available


    May 2020
  73. NAVARESE EP, Khan SU, Kolodziejczak M, Kubica J, et al
    Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.120.046786.
    PubMed     Abstract available


  74. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    PubMed     Abstract available


    March 2020
  75. PARK DW, Ahn JM, Park H, Yun SC, et al
    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046039.
    PubMed    


  76. ALFONSO F, Kastrati A
    Ten-Year Follow-Up of Left Main Coronary Artery Revascularization: Still Equipoise Between Percutaneous Interventions and Surgery?
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046154.
    PubMed    


  77. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: